Menu
Science and research

Professional Publications

Author
Title
Year of publication

Publications (3663)

[541]

Májek, P.; Riedelová-Reicheltová, Z.; Suttnar, J.; Dyr, J.E.

Staining of proteins for 2D SDS-PAGE using Coomassie Blue-speed versus sensitivity?

[year of publication 2013, impact factor 3.161 ]

[542]

Ludajic, K.; Balavarca, Y.; Bickeböller, H.; Rosenmayr, A.; Fischer, G.F.; Faé, I.; Kalhs, P.; Pohlreich, D.; Kouba, M.; Dobrovolná, M.; Grienix, H.T.

Minor ABO-mismatches are risk factors for acute graft-versus-host disease in hematopoietic stem cell transplant patients

[year of publication 2009, impact factor 3.149]

[543]

Kuzmina, Z.; Greinix, H.T.; Knobler, R.; Worel, N.; Kouba, M.; Weigl, R.; Körmöczi, U.; Rottal, A.; Pohlreich, D.; Zielinski, C.; Pickl, W.F.

Proportions of immature CD19+CD21- B lymphocytes predict the response to extracorporeal photopheresis in patients with chronic graft-versus-host disease

[year of publication 2009, impact factor 3.149]

[544]

Petrak, J.; Myslivcova, D.; Man, P.; Cmejlova, J.; Cmejla, R.; Vyoral, D.

Proteomic analysis of erythroid differentiation induced by hexamethylene bisacetamide in murine erythroleukemia cells

[year of publication 2007, impact factor 3.147]

[545]

Bruchova, H.; Yoon, D.; Agarwal, A. M.; Mendell, J.; Prchal, J. T.

Regulated expression of miRNAs in normal and polycythemia vera erythropoiesis

[year of publication 2008, impact factor 3.147]

[546]

Tachezy, R.; Mikyskova, I.; Salakova, M.; Van Ranst, M.

Correlation between human papillomavirus-associated cervical cancer and p53 codon 72 arginine/proline polymorphism.

[year of publication 2007, impact factor 3.145]

[547]

Šašinková, M.; Holoubek, A.; Otevřelová, P.; Kuželová, K.; Brodská, B.

AML-associated mutation of nucleophosmin compromises its interaction with nucleolin

[year of publication 2018, impact factor 3.144 ]

[548]

Machova Polakova, K.; Kulvait, V.; Benesova, A.; Linhartova, J.; Klamova, H.; Jaruskova, M.; de Benedittis, C.; Haferlach, T.; Baccarani, M.; Martinelli, G.; Stopka, T.; Ernst, T.; Hochhaus, A.; Kohlmann, A.; Soverini, S.

Next-generation deep sequencing improves detection of BCR-ABL1 kinase domain mutations emerging under tyrosine kinase inhibitor treatment of chronic myeloid leukemia patients in chronic phase

[year of publication 2014, impact factor 3.141 ]

[549]

Salaj, P.; Penka, M.; Smejkal, P.; Geierova, V.; Ovesna, P.; Brabec, P.; Cetkovsky, P.; Kubes, R.; Mesterton, J.; Lindgren, P.

Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: haemophilia registry data from the Czech Republic

[year of publication 2012, impact factor 3.133 ]

[550]

Matoušek, J.; Poučková, P.; Souček, J.; Škvor, J.

PEG chains increase aspermatogenic and antitumor activity of RNase A and BS-RNase enzymes

[year of publication 2006, impact factor 3.131]

[551]

Marešová, L.; Kutinová, L.; Ludvíková, V.; Žák, R.; Mareš, M.; Němečková, Š.

Characterization of interaction of gH and gL glycoproteins of varicella-zoster virus : their processing and trafficking

[year of publication 2006, impact factor 3.126]

[552]

Toracchio, S.; Kozinetz, C.A.; Killen, D.E.; Sheehan, A.M.; Banez, E.I.; Ittmann, M.M.; Sroller, V.; Butel, J.S.

Variable frequency of polyomavirus SV40 and herpesvirus EBV in lymphomas from two different urban population groups in Houston, TX

[year of publication 2009, impact factor 3.124]

[553]

Kuželová, K.; Pluskalová, M.; Brodská, B.; Otevřelová, P.; Elknerová, K.; Grebeňová, D.; Hrkal, Z.

Suberoylanilide hydroxamic acid (SAHA) at subtoxic concentrations increases the adhesivity of human leukemic cells to fibronectin

[year of publication 2009, impact factor 3.122]

[554]

Kuželová, K.; Pluskalová, M.; Grebeňová, D.; Pavlásková, K.; Halada, P.; Hrkal, Z.

Changes in cell adhesivity and cytoskeleton-related proteins during imatinib-induced apoptosis of leukemic JURL-MK1 cells

[year of publication 2010, impact factor 3.122]

[555]

Cukrová, V.; Neuwirtová, R.; Doležalová, L.; Beličková, M.; Bartůňková, J.; Jonášová, A.; Čermák, J.; Homolková, H.; Malíková, I.

Defective cytotoxicity of T lymphocytes in myelodysplastic syndrome

[year of publication 2009, impact factor 3.106]

[556]

Šmahel, M.; Poláková, I.; Dušková, M.; Ludvíková, V.; Kaštánková, I.

The effect of helper epitopes and cellular localization of an antigen on the outcome of gene gun DNA immunization

[year of publication 2014, impact factor 3.104 ]

[557]

Garaj, M.; Durila, M.; Vajter, J.; Solcova, M.; Marecek, F.; Hrachovinová, I.

Extracorporeal membrane oxygenation seems to induce impairment of primary hemostasis pathology as measured by a Multiplate analyzer: An observational retrospective study

[year of publication 2022, impact factor 3.094 ]

[558]

Brodská, B.; Holoubek, A.; Otevřelová, P.; Kuželová, K.

Low-dose actinomycin-D induces redistribution of wild-type and mutated nucleophosmin followed by cell death in leukemic cells

[year of publication 2015, impact factor 3.085 ]

[559]

Racil, Z.; Razga, F.; Klamova, H.; Voglova, J.; Belohlavkova, P.; Malaskova, L.; Potesil, D.; Muzik, J.; Zackova, D.; Machova Polakova, K.; Zdrahal, Z.; Malakova, J.; Suttnar, J.; Dyr, J.; Mayer, J.

No clinical evidence for performing trough plasma and intracellular imatinib concentrations monitoring in patients with chronic myelogenous leukaemia

[year of publication 2013, impact factor 3.084 ]

[560]

Dvorak, P.; Lysak, D.; Vokurka, S.; Michalova, K.; Sarova, I.; Jonasova, A.; Hruba, M.; Rykovska, A.; Subrt, I.

The translocation t(2;11)(p21;q23) without MLL gene rearrangement: a possible marker of good prognosis in myelodysplastic syndrome patients

[year of publication 2013, impact factor 3.084 ]


Quick contact

Head of Science and Research Division
Tel:+420 221 977 305

Deputy head of Science and Research Division
Tel:+420 221 977 648

Secretary
Tel:+420 221 977 144


Opening hours

Ambulance
Mo – Fr: 7:00–18:00
Weekends: 9:00–13:00

Donors
Mo – Fr: 7:00–10:30

Visitors
Inpatient department
Mo – Fr: 13:00–18:00

ICU and Transplant unit
Mo – Fr: 14:00–17:00

How to find us

map

Ústav hematologie a krevní transfuze
(​Institute of Hematology and Blood Transfusion)

U Nemocnice 2094/1
128 00 Praha 2

The nearest underground station: Karlovo náměstí (line B)

The nearest tram station: Karlovo náměstí (10, 16, 22), Moráň (3, 6, 10, 16, 18, 24)

The nearest bus station: U Nemocnice (148), Karlovo náměstí (176)

How to get here